OTCMKTS:AMBBY Ambu A/S (AMBBY) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free AMBBY Stock Alerts $15.85 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$15.85▼$15.8550-Day Range$15.30▼$17.4852-Week Range$9.45▼$17.48Volume13 shsAverage Volume207 shsMarket Capitalization$3.72 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Ambu A/S alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Ambu A/S Stock (OTCMKTS:AMBBY)Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.Read More AMBBY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMBBY Stock News HeadlinesFebruary 9, 2024 | finance.yahoo.comAmbu A/S: Reporting of transactions made by persons discharging managerial responsibilitiesFebruary 6, 2024 | finance.yahoo.comGRANT OF PERFORMANCE SHARE UNITSApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.February 4, 2024 | msn.comWhy Anisa Percival's breakout scoring night bodes well for the Ames girls basketball teamFebruary 4, 2024 | morningstar.comAmbu A/S Class B AMBU BJanuary 31, 2024 | realmoney.thestreet.comAmbu price target raised by DKK 5 at JPMorganJanuary 30, 2024 | finance.yahoo.comINTERIM REPORT FOR Q1 2023/24January 16, 2024 | realmoney.thestreet.comHandelsbanken gets more bearish on Ambu, downgrades sharesApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.December 15, 2023 | uk.investing.comAmbu A/S (0MJF)December 13, 2023 | morningstar.comAmbu A/S Class B AMBFFNovember 8, 2023 | finance.yahoo.comAMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEARNovember 8, 2023 | finance.yahoo.comANNUAL REPORT 2022/23 (EARNINGS RELEASE)October 11, 2023 | finance.yahoo.comAMBU APPOINTS NEW CHIEF FINANCIAL OFFICEROctober 9, 2023 | finance.yahoo.comAMBU ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE FISCAL YEAR 2022/23September 29, 2023 | bbc.co.ukA 360° King's coronation view inside Westminster AbbeySeptember 29, 2023 | finance.yahoo.comAMBU FINANCIAL CALENDAR FOR 2023/24August 31, 2023 | finance.yahoo.comINTERIM REPORT FOR Q3 2022/23August 30, 2023 | markets.businessinsider.comAmbu A-S Bearer and-or registered B is about to announce earnings — here's what Wall Street expectsAugust 16, 2023 | forbes.comEarning A Master’s In Homeland Security: What To KnowJuly 28, 2023 | finance.yahoo.comGrant of Performance Share Units and reporting of transactions in accordance with Article 19 of the Market Abuse RegulationJuly 25, 2023 | nbcnews.comIn one of the world's deadliest cities, a musician's idea pays offJuly 22, 2023 | health.usnews.comDr. Abbey S. HawkinsJuly 10, 2023 | finance.yahoo.comAMBU UPGRADES FULL-YEAR 2022/23 EARNINGS EXPECTATIONS ON THE BACK OF PRELIMINARY Q3 2022/23 RESULTSMay 19, 2023 | usatoday.comFelony charges, no trial: How a traffic stop upended her life for three yearsMay 3, 2023 | finance.yahoo.comINTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEARMarch 28, 2023 | finance.yahoo.comREGISTRATION OF SHARE CAPITAL INCREASE OF 11,577,957 NEW B SHARES COMPLETEDSee More Headlines Receive AMBBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ambu A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Holding & other investment offices Sub-IndustryN/A Current SymbolOTCMKTS:AMBBY Previous SymbolOTCMKTS:AMBBY CUSIPN/A CIKN/A Webwww.ambu.com Phone(457) 225-2000FaxN/AEmployees4,400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares234,970,000Free FloatN/AMarket Cap$3.72 billion OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMs. Britt Meelby Jensen (Age 51)Chief Executive Officer Comp: $1.93MHolger HesseFounderMr. Henrik Skak BenderExecutive VP & CFOHenrik Birk (Age 50)Chief Operations Officer Mr. Finn Mohring (Age 59)Chief Technology Officer Mr. Nicolai ThomsenDirector of Investor Relations & Strategic Financial PlanningMikkel Trier WagnerDirector of Corporate CommunicationsRummana HasanChief Marketing OfficerMr. Thomas Lykke Henriksen (Age 51)Head of HR Systems Comp: $10.29kMr. Måns BarsneExecutive VP of Global Innovation & Chief Innovation OfficerMore ExecutivesKey CompetitorsRyman HealthcareOTCMKTS:RYHTYSonic HealthcareOTCMKTS:SKHHYCymaBay TherapeuticsNASDAQ:CBAYImmunityBioNASDAQ:IBRXUltragenyx PharmaceuticalNASDAQ:RAREView All Competitors AMBBY Stock Analysis - Frequently Asked Questions Should I buy or sell Ambu A/S stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ambu A/S in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AMBBY shares. View AMBBY analyst ratings or view top-rated stocks. How have AMBBY shares performed in 2024? Ambu A/S's stock was trading at $15.30 on January 1st, 2024. Since then, AMBBY shares have increased by 3.6% and is now trading at $15.8475. View the best growth stocks for 2024 here. Are investors shorting Ambu A/S? Ambu A/S saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 400 shares, a decline of 82.6% from the March 31st total of 2,300 shares. Based on an average trading volume of 700 shares, the short-interest ratio is presently 0.6 days. View Ambu A/S's Short Interest. How do I buy shares of Ambu A/S? Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AMBBY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambu A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
